| Literature DB >> 31866066 |
Daohua Jiang1, Hui Shi2, Lige Tonggu1, Tamer M Gamal El-Din1, Michael J Lenaeus3, Yan Zhao4, Craig Yoshioka4, Ning Zheng5, William A Catterall6.
Abstract
Voltage-gated sodium channel Nav1.5 generates cardiac action potentials and initiates the heartbeat. Here, we report structures of NaV1.5 at 3.2-3.5 Å resolution. NaV1.5 is distinguished from other sodium channels by a unique glycosyl moiety and loss of disulfide-bonding capability at the NaVβ subunit-interaction sites. The antiarrhythmic drug flecainide specifically targets the central cavity of the pore. The voltage sensors are partially activated, and the fast-inactivation gate is partially closed. Activation of the voltage sensor of Domain III allows binding of the isoleucine-phenylalanine-methionine (IFM) motif to the inactivation-gate receptor. Asp and Ala, in the selectivity motif DEKA, line the walls of the ion-selectivity filter, whereas Glu and Lys are in positions to accept and release Na+ ions via a charge-delocalization network. Arrhythmia mutation sites undergo large translocations during gating, providing a potential mechanism for pathogenic effects. Our results provide detailed insights into Nav1.5 structure, pharmacology, activation, inactivation, ion selectivity, and arrhythmias.Entities:
Keywords: antiarrhytymic drugs; cryoelectron microscopy arrhythmia; fast inactivation; gating pore current; heart; sodium channel; sodium selectivity
Mesh:
Substances:
Year: 2019 PMID: 31866066 PMCID: PMC6986426 DOI: 10.1016/j.cell.2019.11.041
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582